Human health risk assessment of penicillin/aminopenicillin resistance in enterococci due to penicillin use in food animals

Risk Analysis

Volumn 29, Issue 6, 2009, Pages 796-805

  Cox, Louis Anthony ^a,b,e   Popken, Douglas A ^a,c   Mathers, Jeremy J ^d  

^a Cox Associates ^*  (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Systems View   (United States)

^d Alpharma Animal Health Division

^e NONE   (United States)

Author keywords

Animal antimicrobials; Enterococcus; Penicillin; Resistance; Risk assessment

Indexed keywords

DISEASE CONTROL; ELECTRIC RESISTANCE; HEALTH RISKS; INTENSIVE CARE UNITS; MAMMALS; RISK PERCEPTION; UNCERTAINTY ANALYSIS;

AT-RISK POPULATION; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; HUMAN HEALTH RISK ASSESSMENT; HUMAN HEALTH RISKS; HUMAN INFECTION; PENICILLIN; SCIENTIFIC UNCERTAINTY;

RISK ASSESSMENT;

AMINOPENICILLIN; PENICILLIN G;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; CAUSE OF DEATH; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DRUG RESISTANCE; HEALTH RISK; PUBLIC HEALTH; RISK ASSESSMENT;

ANIMAL; ARTICLE; DRUG USE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; HEALTH HAZARD; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; MORTALITY; NONHUMAN; PENICILLIN ALLERGY; PENICILLIN RESISTANCE; PREVALENCE; RISK ASSESSMENT; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

NORTH AMERICA; UNITED STATES;

ANIMALIA; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; SUIDAE;

EID: 65549120826     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2009.01202.x     Document Type: Article

References (43)

1. American Veterinary Medical Association (AVMA). American Veterinary Medical Association Judicious Therapeutic Use of Antimicrobials December, 2005. Available at http://www.avma.org/issues/jtua/default.asp, 2008 (accessed December 31, 2008).
2. Animal Health Institute (AHI). Animal Health Companies Meet Increase Market Need for Antibiotics. Washington, DC : News Release from the Animal Health Institute, October 12, 2006. Available at http://www.ahi.org/mediacenter/ documents/Antibioticuse2005REVISED.pdf (accessed December 31, 2008).
3. Austin DJ, Bonten MJM, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs. Proceedings of National Academy of Sciences of USA, 1999 96 : 6908 6913. Available at http://www.pnas.org/ (accessed December 31, 2008).
4. Biavasco F, Foglia G, Paoletti C, Zandri G, Magi G, Guaglianone E, Sundsfjord A, Pruzzo C, Donelli F, Facinelli B. VanA-type Enterococci from humans, animals and food: Species distribution, population structure, Tn1546-typing and location, and virulence determinants. Applied and Environmental Microbiology, 2007 73 (10 3307 3319. (Pubitemid 46834983)
5. Bischoff WE, Reynolds TM, Hall GO, Wenzel RP, Edmond MB Molecular epidemiology of vancomycin resistant Enterococcus faecium in a large urban hospital over a 5-year period. Journal of Clinical Microbiology, 1999 37 (12 3912 3916.
6. Cox LA, Popken DA. Quantifying human health risks from virginiamycin used in chickens. Risk Analysis, 2004 24 (1 271 288. (Pubitemid 38269386)
7. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program. Diagnostic Microbiology and Infectious Disease, 2007 58 (2 163 170. (Pubitemid 46856806)
8. Edmond MB, Wallace SE, McClish DK, Pfaller M A, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clinical Infectious Diseases, 1999 29 (2 239 244. (Pubitemid 29380177)
9. FAO/WHO/OIE. Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials. Report of a meeting held in FAO, Rome, Italy, 26-30 November 2007. FAO, Rome, Italy, and WHO, Geneva, Switzerland, 2008.
10. Fortun J, Coque TM, Martin-Davila P, Moreno L, Canton R, Loza E, Baquero F Moreno S. Risk factors associated with ampicillin resistance in patients with bacteraemia caused by Enterococcus faecium. Journal of Antimicrobial Chemotherapy, 2002 50 (6 1003 1009. (Pubitemid 36032824)
11. Guardabassi L, Dalsgaard A. Occurrence, structure, and mobility of Tn1546-like elements in environmental isolates of vancomycin-resistant enterococci. Applied and Environmental Microbiology, 2004 70 (2 984 990. (Pubitemid 38568224)
12. Hanrahan J, Hoyen C, Rice LB. Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains. Antimicrobial Agents and Chemotherapy, 2000 44 : 1349 1351. (Pubitemid 30228318)
13. Hayes JR, English LL, Carr LE, Wagner DD Joseph SW Multiple-antibiotic resistance of Enterococcus spp. isolated from commercial poultry production environments. Applied and Environmental Microbiology, 2004 70 (10 6005 6011. (Pubitemid 39471847)
14. Hayes JR, English LL, Carter PJ, Proescholdt T, Lee KY, Wagner DD, White DG. Prevalence and antimicrobial resistance of Enterococcus species isolated from retail meats. Applied and Environmental Microbiology, 2003 69 (12 7153 7160. (Pubitemid 38585364)
15. Institute of Medicine (IOM). Human Health Risks with the Subtherapeutic Use of Penicillin or Tetracyclines in Animal Feed. Report by the Committee of Human Health Risk Assessment of Using Subtherapeutic Antibiotics in Animal Feeds, Institute of Medicine, IOM-88-89. Washington, DC : National Academy Press, 1989.
16. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP Emerging resistance among bacterial pathogens in the intensive care unit - A European and North American surveillance study (2000-2002). Annals of Clinical Microbiology and Antimicrobials, 2004 3 (14 1 11. Available at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=509280 (accessed December 31, 2008). (Pubitemid 41630813)
17. Kuhn I, Iversen A, Finn M, Greko C, Burman LG, Blanch AR, Vilanova X, Manero A, Taylor H, Caplin J, Dominguez L, Herrero IA, Moreno MA, Mollby R. Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Applied and Environmental Microbiology, 2005 71 (9 5383 5390. (Pubitemid 41338272)
18. Leavis HL, Bonten MJ. Willems RJ. Identification of high-risk enterococcal clonal complexes; global dispersion and antibiotic resistance. Current Opinions in Microbiology, 2006 9 (5 454 460. (Pubitemid 44397629)
19. Leavis HL, Willems RJ, van Wamel WJ, Schuren FH, Caspers MP, Bonten MJ. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathogens, 2007 3 (1 e7. (Pubitemid 46168848)
20. Leavis HL, Willems RJ, Top J, Spalburg E, Mascini EM, Fluit AC, Hoepelman A, de Neeling AJ, Bonten MJ. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerging Infectious Diseases, 2003 9 (9 1108 1115. (Pubitemid 37071553)
21. Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, Noskin GA. The incidence of antimicrobial allergies in hospitalized patients: Implications regarding prescribing patterns and emerging bacterial resistance. Archives of Internal Medicine, 2000 160 (18 2819 2822.
22. Macovei L, Zurek L. Ecology of antibiotic resistance genes: Characterization of enterococci from houseflies collected in food settings. Applied and Environmental Microbiology, 2006 72 (6 4028 4035. (Pubitemid 43894867)
23. McGowan LL, Jackson CR, Barrett JB, Hiott LM, Fedorka-Cray. Prevalence and antimicrobal resistance of enterococci isolated from retail fruits, vegetables, and meats. Journal of Food Protection, 2006 69 (12 2976 2982.
24. Murray BE. Vancomycin-resistant enterococcal infections. New England Journal of Medicine, 2000 342 (10 710 721. (Pubitemid 30131425)
25. National Antimicrobial Resistance Monitory System (NARMS). NARMS Retail Meat Annual Reports, 2002-2005. Available at http://www.fda.gov/cvm/narms-pg. html#Publications (accessed December 31, 2008).
26. Patton BS, Cast WR, Kocher ME, Matthews JO, Griffith RW, Hurd HS, Dickson JS. The Effect of Swine Production System on Bacterial Prevalence and Antibiotic Resistance. Proccedings of the Poster Presentation at International Association for Food Protection (IAFP) 2006, Calgary, Alberta, Canada, August 13-16, 2006. Abstract available at http://www.foodprotection.org/ meetingsEducation/IAFP%202006/IAFP%2006%20Poster%20Abstracts.pdf (accessed December 31, 2008).
27. Rice LB. Emergence of vancomycin resistant enterococci. Emerging Infectious Diseases, 2001 7 (2 183 187.
28. Rodrigues J, Poeta P, Martins A, Costa D. The importance of pets as reservoirs of resistant Enterococcus strains, with special reference to vancomycin. Journal of Veterinary Medicine B, 2002 49 (6 278 280.
29. Sechen S. The review of animal production drugs by FDA. FDA Veterinarian, 2006 21 (1 8 11. Available at http://www.fda.gov/cvm/Documents/FDAVetVolXXINo1. pdf (accessed December 31, 2008).
30. Suppola J, Kolho E, Salmenlinna S, Tarkka E, Vuopio-Varkila J, Vaara M. VanA and VanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: Effect on interpretation of clonality. Journal of Clinical Microbiology, 1999 37 (12 3934 3939.
31. Top J, Willems R, Blok H, de Regt M, Jalink K, Troelstra A, Goorhuis B, Bonten M. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex-17 Enterococcus faecium. Clinical Microbiology and Infection, 2007 13 (3 316 319. (Pubitemid 46603364)
32. U.S. Food and Drug Administration - Center for Veterinary Medicine (FDA-CVM). FDA Database of Approved Animal Drug Products. FDA Center for Veterinary Medicine, VMRCVM Drug Information Lab, 2007, Available at http://dil.vetmed.vt.edu/ (accessed December 31, 2008).
33. U.S. Food and Drug Administration - Center for Veterinary Medicine (FDA-CVM). Risk Assessment of Streptogramin Resistance in Enterococcus Faecium Attributable to the Use of Streptogramins in Animals. Draft for Comment, November 23, 2004. Available at http://www.fda.gov/cvm/Documents/SREF-RA- FinalDraft.pdf (accessed December 31, 2008).
34. U.S. Food and Drug Administration - Center for Veterinary Medicine (FDA-CVM). Guidance for Industry no 152: Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Veterinary Medicine, 2003. Available at http://www.fda.gov/cvm/Guidance/fguide152.pdf (accessed December 31, 2008).
35. U.S. Food and Drug Administration - Center for Veterinary Medicine (FDA-CVM). Review of Agricultural Antibiotics Policies, 2000. Available at http://www.fda.gov/cvm/HRESP106-157.htm#nrdc (accessed December 31, 2008).
36. Varman M, Chatterjee A, Abuhammour W, Johnson WC. Enterococcal infection, 2006. Emedicine.com. Available at http://www.emedicine.com/ped/topic2703.htm (accessed July 26, 2006).
37. Webb M, Riley LW, Roberts RB. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clinical Infectious Diseases, 2001 33 (4 445 452. (Pubitemid 32709574)
38. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerging Infectious Diseases, 2005 11 (6 821 828. (Pubitemid 40720841)
39. Willems RJ, Horman W, Top J, van Santen-Verheuvel M, Tribe D, Manzioros X, Gaillard C, Vandenbroucke-Grauls CMJE, Mascini EM, van Kregten E, van Embden JDA Bonten MJ. Variant esp gene as a marker of a distinct genetic lineage of vancomycin resistant Enterococcus faecium spreading in hospitals. Lancet, 2001 357 (9259 853 855. (Pubitemid 32239372)
40. Willems RJ, Top J, Van Den Braak N, van Belkum A, Endtz H, Mevius D, Stobberingh E, Van Den Bogaard A, van Embden JDA. Host specificity of vancomycin-resistant Enterococcus faecium. Journal of Infectious Diseases, 2000 182 (3 816 823.
41. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases, 2004 39 (3 309 317. (Pubitemid 39050477)
42. World Health Organization (WHO). Critically Important Antibacterial Agents for Human Medicine for Risk Management Strategies of Non-Human Use. Report of a WHO Working Group Consultation February 15-18, 2005. Canberra, Australia, 2005. Available at http://www.who.int/entity/foodborne-disease/ resistance/FBD-CanberraAntibacterial-FEB2005.pdf (accessed December 31, 2008).
43. World Health Organization (WHO). Joint FAO/WHO/OIE Meeting on Critically Important Antimicrobials. Report of the FAO/WHO/OIE Expert Meeting. FAO Rome Italy. November 26-30, 2007. Available at http://www.who.int/foodborne-disease/ resources/Report%20joint%20CIA%20Meeting.pdf (accessed December 31, 2008).